Laobaixing Pharmacy (603883) — Cash Flow-to-Debt Ratio
Laobaixing Pharmacy (603883) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥538.25 Million could theoretically repay 0% of its total liabilities (CN¥13.13 Billion) in one year. Explore Laobaixing Pharmacy long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Laobaixing Pharmacy Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Laobaixing Pharmacy across 15 annual periods. Also explore 603883 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Laobaixing Pharmacy (2011–2025)
Year-by-year debt coverage analysis for Laobaixing Pharmacy. For market capitalisation and broader financial context, see how much is Laobaixing Pharmacy worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | CN¥3.14 Billion | CN¥12.85 Billion | ▲ +80.9% |
| 2024 | 0.14x | CN¥2.03 Billion | CN¥14.99 Billion | ▼ -31.0% |
| 2023 | 0.20x | CN¥2.73 Billion | CN¥13.94 Billion | ▲ +21.0% |
| 2022 | 0.16x | CN¥2.31 Billion | CN¥14.30 Billion | ▼ -14.2% |
| 2021 | 0.19x | CN¥2.30 Billion | CN¥12.18 Billion | ▼ -15.5% |
| 2020 | 0.22x | CN¥1.45 Billion | CN¥6.48 Billion | ▲ +30.9% |
| 2019 | 0.17x | CN¥1.03 Billion | CN¥6.05 Billion | ▼ -4.4% |
| 2018 | 0.18x | CN¥913.03 Million | CN¥5.12 Billion | ▲ +30.5% |
| 2017 | 0.14x | CN¥492.13 Million | CN¥3.60 Billion | ▲ +29.4% |
| 2016 | 0.11x | CN¥313.26 Million | CN¥2.96 Billion | ▼ -38.0% |
| 2015 | 0.17x | CN¥257.15 Million | CN¥1.51 Billion | ▼ -0.4% |
| 2014 | 0.17x | CN¥247.14 Million | CN¥1.44 Billion | ▲ +58.4% |
| 2013 | 0.11x | CN¥136.52 Million | CN¥1.26 Billion | ▼ -35.9% |
| 2012 | 0.17x | CN¥148.85 Million | CN¥882.72 Million | ▲ +16.1% |
| 2011 | 0.15x | CN¥132.62 Million | CN¥912.83 Million | — |